| P2093 | author name string | E Keshet | |
| | G Meir | |
| | M Neeman | |
| | R Abramovitch | |
| | N Nevo | |
| | Y S Schiffenbauer | |
| | A Itin | |
| | M Holzinger | |
| P2860 | cites work | Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis | Q24684263 |
| | Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 |
| | Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 |
| | A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples | Q34721532 |
| | Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis | Q34729610 |
| | Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75. | Q35614963 |
| | Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours | Q36467040 |
| | Endocrine Factors in Common Epithelial Ovarian Cancer* | Q37176622 |
| | Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes | Q40017265 |
| | Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: where are we today? | Q40690543 |
| | Cell and environment interactions in tumor microregions: the multicell spheroid model | Q41280817 |
| | GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transience | Q41495978 |
| | Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. | Q42805124 |
| | Augmentative effects of intracellular chemotherapy penetration combined with hyperthermia in human ovarian cancer cells lines | Q42806961 |
| | Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. | Q44393459 |
| | Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker. | Q44618451 |
| | Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. | Q52210495 |
| | Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. | Q54241107 |
| | Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy. | Q55480047 |
| | Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. | Q55480864 |
| | Ovarian tumors in a cohort of infertile women | Q72139399 |
| | Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression | Q72270437 |
| | Vascular permeability factor gene expression in normal and neoplastic human ovaries | Q72657644 |
| | Short report: identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts | Q72899617 |
| | In vivo neutralization of vascular endothelial growth factor (VEGF) vascular permeability factor (VPF) inhibits ovarian carcinoma-associated ascites formation and tumor growth | Q84040170 |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian carcinoma | Q18556145 |
| P304 | page(s) | 13203-13208 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Loss of ovarian function promotes angiogenesis in human ovarian carcinoma | |
| P478 | volume | 94 | |